Complete Filing Data
Highview Merger Corp. reported Stockholders Equity of -$8.28 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Highview Merger Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Net Income Loss | $988.2K | -$46.8K |
| Operating Income Loss | -$168.3K | -$46.8K |
| General And Administrative Expense | $168.3K | $46.8K |
| Payment Of General And Administrative Costs Through Promissory Note Related Party | -$2.2K | |
| Nonoperating Income Expense | $1.2M | |
| Payment Of General And Administrative Costs In Exchange For Issuance Of Class B Ordinary Shares | -25.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$8.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $900.4K |
| Retained Earnings Accumulated Deficit | -$8.3M |
| Preferred Stock Value | $0.00 |
| Liabilities And Stockholders Equity | $234.7M |
| Liabilities | $9.4M |
| Deferred Offering Costs Included In Accrued Offering Costs | |
| Commitments And Contingencies | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |
| Assets | $234.7M |
| Accrued Offering Costs | $75.0K |
| Accrued Liabilities Current | $94.1K |
| Temporary Equity Carrying Amount Attributable To Parent | $233.6M |
| Other Receivables Net Current | $25.0K |
| Liabilities Current | $169.1K |
| Deferred Underwriting Fee Payable Non Current | $9.2M |
| Cash And Cash Equivalents At Carrying Value | $900.4K |
| Assets Held In Trust Noncurrent | $233.6M |
| Assets Current | $1.0M |
| Notes Payable Current | |
| Deferred Offering Costs | |
| Adjustments To Additional Paid In Capital Accretion For Common Stock To Redemption Amount |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Stockholders Equity | -$8.0M | -$21.8K | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0M | $0.00 | |
| Retained Earnings Accumulated Deficit | -$8.0M | -$46.8K | |
| Preferred Stock Value | $0.00 | $0.00 | |
| Liabilities And Stockholders Equity | $232.6M | $326.0K | |
| Liabilities | $9.3M | $347.8K | |
| Deferred Offering Costs Included In Accrued Offering Costs | $291.0K | ||
| Commitments And Contingencies | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $0.00 | ||
| Assets | $232.6M | $326.0K | |
| Accrued Offering Costs | $75.0K | $291.0K | |
| Accrued Liabilities Current | $28.3K | $19.5K | |
| Temporary Equity Carrying Amount Attributable To Parent | $231.3M | ||
| Other Receivables Net Current | $25.0K | ||
| Liabilities Current | $103.3K | ||
| Deferred Underwriting Fee Payable Non Current | $9.2M | ||
| Cash And Cash Equivalents At Carrying Value | $1.0M | ||
| Assets Held In Trust Noncurrent | $231.3M | ||
| Assets Current | $1.2M | ||
| Notes Payable Current | $37.2K | ||
| Deferred Offering Costs | $326.0K | ||
| Adjustments To Additional Paid In Capital Accretion For Common Stock To Redemption Amount | -$18.3M |
Cash Flow Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Proceeds From Related Party Debt | $35.0K | |
| Net Cash Provided By Used In Operating Activities | $0.00 | |
| Net Cash Provided By Used In Financing Activities | $0.00 | |
| Allocated Share Based Compensation Expense | $154.7K | |
| Payments Of Financing Costs | $35.0K | |
| Increase Decrease In Accrued Liabilities | $19.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Preferred Stock Shares Outstanding | 0.00 |
| Preferred Stock Shares Issued | 0.00 |
| Preferred Stock Shares Authorized | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | |
| Weighted Average Number Of Diluted Shares Outstanding | |
| Earnings Per Share Diluted | |
| Earnings Per Share Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 5.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 5.0M | |
| Earnings Per Share Diluted | $-0.01 | |
| Earnings Per Share Basic | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Issued During Period Value New Issues | |
| Investment Income Interest | |
| Additional Paid In Capital | $0.00 |
| Stock Issued During Period Value Sale Of Private Placement Units | |
| Sale Of Private Placement Units | |
| Prepaid Insurance Non Current | $58.5K |
| Prepaid Expense Current | $108.0K |
| Adjustments To Additional Paid In Capital Fair Value Of Founder Shares Assigned To Directors | |
| Adjustments To Additional Paid In Capital Allocated Value Of Transaction Costs To Class A Shares | |
| Adjustments To Additional Paid In Capital Warrant Issued |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stock Issued During Period Value New Issues | $25.0K | |
| Investment Income Interest | $1.3M | |
| Additional Paid In Capital | $0.00 | $24.4K |
| Stock Issued During Period Value Sale Of Private Placement Units | $6.6M | |
| Sale Of Private Placement Units | $660.0K | |
| Prepaid Insurance Non Current | $82.3K | |
| Prepaid Expense Current | $136.7K | |
| Adjustments To Additional Paid In Capital Fair Value Of Founder Shares Assigned To Directors | 155.0K | |
| Adjustments To Additional Paid In Capital Allocated Value Of Transaction Costs To Class A Shares | 188.8K | |
| Adjustments To Additional Paid In Capital Warrant Issued | $2.7M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.